Ecnoglutide clinical trials
Also written XW003.
How each study uses ecnoglutide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ecnoglutide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 3 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 0
Hangzhou Sciwind Biosciences Co., Ltd. (11) · Sciwind Biosciences APAC CO Pty. Ltd. (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test ecnoglutide.
- Jan 2027A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityPhase 1/2 · Hangzhou Sciwind Biosciences Co., Ltd.
- Feb 2027A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)Phase 2 · Hangzhou Sciwind Biosciences Co., Ltd.
Studies
Open first, then newest update. How each study uses ecnoglutide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or ObesityRecruitingPhase 1/2Hangzhou Sciwind Biosciences Co., Ltd.NCT07243171Written as ecnoglutide tablets
- A Study of Ecnoglutide Injection in Overweight or Obese Chinese AdolescentsNot yet recruitingPhase 3Hangzhou Sciwind Biosciences Co., Ltd.NCT07836270Written as Ecnoglutide Injection
- A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)RecruitingPhase 3Hangzhou Sciwind Biosciences Co., Ltd.NCT07734311Written as Ecnoglutide Injection
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure TherapyRecruitingPhase 3Hangzhou Sciwind Biosciences Co., Ltd.NCT07387094Written as XW003 injection
- A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure TherapyRecruitingPhase 3Hangzhou Sciwind Biosciences Co., Ltd.NCT07434050Written as XW003 injection
- A Study of XW003 Injection in Chinese Adolescents With ObesityCompletedPhase 1Hangzhou Sciwind Biosciences Co., Ltd.NCT07143227Written as XW003 injection
- A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)Active, not recruitingPhase 2Hangzhou Sciwind Biosciences Co., Ltd.NCT07073417Written as XW003 injection
- A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM PatientsCompletedPhase 3Hangzhou Sciwind Biosciences Co., Ltd.NCT05680155Written as Ecnoglutide
- A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DMCompletedPhase 3Hangzhou Sciwind Biosciences Co., Ltd.NCT05680129Written as Ecnoglutide high dosage
- A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or DigoxinCompletedPhase 1Hangzhou Sciwind Biosciences Co., Ltd.NCT06335134Written as XW003 injection
- A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or ObesityCompletedPhase 3Hangzhou Sciwind Biosciences Co., Ltd.NCT05813795Written as Ecnoglutide Low Dosage
- Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With ObesityCompletedPhase 2Sciwind Biosciences APAC CO Pty. Ltd.NCT05111912Written as XW003
Given beside what is tested · 1 — ecnoglutide is usual care or a partner of the new treatment
Codes
What other systems call ecnoglutide · ClinicalTrials.gg INT017079
- UNII (FDA) KM6YM7L8LHECNOGLUTIDEConfirmed FDA, Wikidata
- Wikidata Q123481340ecnoglutideConfirmed FDA, Wikidata
- NCI Thesaurus C188592EcnoglutideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | KM6YM7L8LH | ECNOGLUTIDE | Confirmed FDA, Wikidata |
| Wikidata | Q123481340 | ecnoglutide | Confirmed FDA, Wikidata |
| NCI Thesaurus | C188592 | Ecnoglutide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.